Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CA3 | P07451 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 2/20 | 0.42 |
| ▸ | CA5A | P35218 | 2/20 | 0.42 |
| ▸ | THPO | P40225 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL472164 | 0.93 | ESR1 (0.50) | HSD17B10KDM4EALDH1A1HPGDMEN1 | |
| P-Cresol SCHEMBL472079 | 0.89 | ACHE (0.54) | HSD17B10KDM4EALDH1A1HPGDMEN1 | |
| Phenol SCHEMBL245441 | 0.88 | CA12 (0.50) | HSD17B10ALDH1A1HPGDCYP3A4MEN1 | |
| Phenol SCHEMBL587707 | 0.88 | CA12 (0.50) | HSD17B10ALDH1A1HPGDCYP3A4MEN1 | |
| SCHEMBL7307672 | 0.86 | IDO1 (0.46) | HSD17B10KDM4EALDH1A1HPGDMEN1 | |
| Phenol SCHEMBL4557362 | 0.86 | CA12 (0.48) | HSD17B10ALDH1A1HPGDCYP3A4MEN1 | |
| SCHEMBL472120 | 0.85 | MMP3 (0.58) | CYP3A4MEN1KMT2AMAPTLMNA | |
| Mequinol SCHEMBL28481655 | 0.85 | ESR2 (0.55) | KDM4EALDH1A1CYP3A4MAPTLMNA | |
| 4-Cyanophenol SCHEMBL8772622 | 0.84 | CA12 (0.59) | ALDH1A1CA2CA12CA3CA9 | |
| Paraben SCHEMBL16636120 | 0.84 | CA2 (0.59) | ALDH1A1HPGDKMT2ACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 942 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118063687-A | Polymer and preparation method and application thereof | 合肥艾普拉斯环保科技有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-114292359-A | Preparation method of novel efficient thickener polyacrylate copolymer | 合肥艾普拉斯环保科技有限公司 | 2022-04-08 | — | — | CN | claimed |
| CN-112592425-A | Preparation method of novel thickener polyacrylate | 合肥艾普拉斯环保科技有限公司 | 2021-04-02 | — | — | CN | claimed |
| CN-109378478-A | A kind of negative electrode of lithium ion battery binder | 珠海光宇电池有限公司 | 2019-02-22 | — | — | CN | claimed |
| WO-2018162626-A1 | SKIN COMPOSITION WITH YOGHURT-LIKE TEXTURE | L'OREAL (FR) | 2018-09-13 | — | — | WO | claimed |
| WO-2017189947-A1 | PHARMACEUTICAL DOSAGE FORMS | ASCENT PHARMACEUTICALS, INC. (US) | 2017-11-02 | — | — | WO | claimed |
| US-20170312226-A1 | PHARMACEUTICAL DOSAGE FORMS | ASCENT PHARMA INC (US) | 2017-11-02 | — | — | US | claimed |
| US-20150342856-A1 | Cationic Comb Copolymers, Preparation Thereof And Use Thereof In Cosmetic, Pharmaceutical And Dermatological Formulations | CLARIANT FINANCE (BVI) LIMITED (VG) | 2015-12-03 | — | — | US | claimed |
| US-9125948-B2 | Ion exchange resin treated to control swelling | COATING PLACE, INC. (US) | 2015-09-08 | — | — | US | claimed |
| US-8883213-B2 | Ion exchange resin treated to control swelling | COATING PLACE, INC. (US) | 2014-11-11 | — | — | US | claimed |
| US-20020198328-A1 | Water-soluble polymers with a water-soluble backbone and side units with a lower critical solution temperature, process for preparing them, aqueous compositions containing them and cosmetic use thereof | L'OREAL (FR) | 2002-12-26 | — | — | US | claimed |
| US-6437068-B2 | THICKENER FOR COSMETIC, DRUGS | CLARIANT GMBH (DE) | 2002-08-20 | — | — | US | claimed |
| US-20020082373-A1 | Fluid thickeners comprising neutralized crosslinked polymers of acrylamidoalkylsulonic acids and N-vinylamides | CLARIANT GMBH | 2002-06-27 | — | — | US | claimed |
| US-6355752-B1 | WATER SOLUBLE AND SWELLABLE; COSMETIC THICKENERS | CLARIANT GMBH (DE) | 2002-03-12 | — | — | US | claimed |
| US-20020028226-A1 | Composition especially in the form of emulsion, gel or aqueous solution, including a crosslinked poly(2-acrylamido-2-methylpropanesulphonic acid) polymer neutralized to at least 90% | L'OREAL | 2002-03-07 | — | — | US | claimed |
| US-6329543-B1 | REACTING CAMPHENE WITH (METH)ACRYLIC ACID IN THE PRESENCE OF SULFURIC ACID AND AT LEAST ONE POLYMERIZATION INHIBITOR | ROEHM GMBH & CO KG (DE) | 2001-12-11 | — | — | US | claimed |
| US-6287543-B1 | CONTAINING CROSSLINKED, NEUTRALIZED POLY(2-ACRYLAMIDO-2-METHYLPROPANESULFONIC ACID) | L'OREAL (FR) | 2001-09-11 | — | — | US | claimed |
| US-6123960-A | Composition based on lipid vesicles and a cross-linked poly(2-acrylamido-2-methylpropane-sulphonic acid) which is at least 90% neutralized | L'OREAL (FR) | 2000-09-26 | — | — | US | claimed |
| US-5891452-A | Cosmetic or dermatological composition containing at least one active principle precursor and a crosslinked poly(2-acrylamido-2-methylpropanesulphonic acid) polymer neutralized to at least 90% | L'OREAL (FR) | 1999-04-06 | — | — | US | claimed |
| US-5879718-A | STORAGE STABLE, LESS IRRITATING | L'OREAL (FR) | 1999-03-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020028226-A1 | Composition especially in the form of emulsion, gel or aqueous solution, including a crosslinked poly(2-acrylamido-2-methylpropanesulphonic acid) polymer neutralized to at least 90% | CUTA, ACR, PARN | HSD17B10 184/4885KDM4E 2550/4885ALDH1A1 166/4885 |
| US-20150342856-A1 | Cationic Comb Copolymers, Preparation Thereof And Use Thereof In Cosmetic, Pharmaceutical And Dermatological Formulations | C9, PARN, SGMS1 | HSD17B10 1346/4885KDM4E 2154/4885ALDH1A1 1923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.